How telomerase activity affects glioma cells' response to temozolomide
Author Information
Author(s): Kanzawa T, Germano I M, Kondo Y, Ito H, Kyo S, Kondo S
Primary Institution: Mount Sinai School of Medicine
Hypothesis
The responsiveness of malignant glioma cells to temozolomide is associated with the level of telomerase activity.
Conclusion
Telomerase activity decreases in sensitive glioma cells after treatment with temozolomide, indicating a potential marker for therapeutic efficacy.
Supporting Evidence
- Temozolomide treatment reduced telomerase activity in sensitive glioma cells.
- TMZ-resistant cells showed no significant decline in telomerase activity.
- O6-benzylguanine enhanced the effect of temozolomide in resistant cells.
Takeaway
This study found that glioma cells that respond well to a drug called temozolomide have lower levels of a protein called telomerase, which helps cancer cells grow.
Methodology
The study used various glioma cell lines to assess the relationship between telomerase activity and sensitivity to temozolomide through cell viability assays and telomerase activity assays.
Limitations
The study primarily focused on specific glioma cell lines, which may not represent all types of malignant gliomas.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website